2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Neurological Disorder Drugs Market?

The increasing prevalence of neurological diseases is enhancing the neurological disorder drugs market. Aging and environmental risks are driving disease rates. Drugs manage symptoms and slow disease progression. In September 2024, the Australian Institute of Health and Welfare projected dementia cases to rise from 411,100 in 2023 to 849,300 by 2058. This growth is propelling the drug market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17207&type=smp

#What is the Growth Potential of the Neurological Disorder Drugs Market, and How Will It Perform by 2034?

The neurological disorder drugs market size has shown significant growth in recent years. It will expand from $84.6 billion in 2024 to $90.09 billion in 2025 at a CAGR of 6.5%. This growth is linked to successful animal trials, new therapeutic developments, rising neurological conditions, supportive government policies, and increased healthcare spending.

The neurological disorder drugs market is expected to reach $114.65 billion in 2029, with a CAGR of 6.2%. The growth is attributed to expanding therapeutic options, disease-modifying treatments, digital biomarkers, and the rising prevalence of neurological diseases. Trends include advancements in drug design, neuroimaging, genetic research, collaborations, and regenerative medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17207

What Are the Key Market Innovations in theNeurological Disorder Drugs Market Over the Coming Years?

Major companies in the neurological disorder drugs market are expanding treatment options with therapies like Ocrelizumab. In February 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced Ocrevus (Ocrelizumab) in India for treating both relapsing-remitting and primary progressive multiple sclerosis. Administered biannually, it targets CD20-positive B cells, reducing disease activity and progression.

Who Are the Top Companies Driving Innovation and Growth in theNeurological Disorder Drugs Market?

Major companies operating in the neurological disorder drugs market are F. Hoffmann-La Roche Ltd, Bayer AG, Sanofi S.A, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company Pvt Ltd, Amgen Inc, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd, Otsuka America Pharmaceutical Inc, Biogen Inc, Bausch Health Companies Inc, Alexion Pharmaceuticals Inc., UCB S.A., Eisai Co Ltd, Cipla Inc, BioMarin Pharmaceutical Inc., Biocon Ltd, Acorda Therapeutics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/neurological-disorder-drugs-global-market-report

Which Key Market Segments Comprise the Neurological Disorder Drugs Market and Drive Its Revenue Growth?

The neurological disorder drugs market covered in this report is segmented –

1) By Drug Class: Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs Classes

2) By Indication: Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Cerebrovascular Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegtments:

1) By Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine

2) By N-Methyl-D-Aspartate (NMDA) Receptor Antagonists: Memantine, Other NMDA Receptor Antagonists

3) By Antiepileptic: Sodium Channel Blockers, GABA Enhancers, Glutamate Modulators, Other Antiepileptics

4) By Antipsychotic and Antidepressant: Risperidone, Olanzapine, SSRIs, SNRIs, Tricyclic

5) By Other Drug Classes: Dopaminergic Drugs, Alpha-2 Agonists, Immunomodulators, Other Neurological Disorder Medications

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=17207&type=smp

Which Regions Are Emerging as Leaders in the Neurological Disorder Drugs Market?

North America was the largest region in the neurological disorder drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurological disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Neurological Disorder Drugs Market 2025, By The Business Research Company:

Myeloproliferative Disorders Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/myeloproliferative-disorders-drugs-global-market-report

Neurological Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

Bleeding Disorders Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: